A spotlight from prostate cancer.

Cancer Discovery
Harvey R Herschman, Johannes Czernin

Abstract

Serum prostate-specific antigen (PSA) levels are used to monitor the development of prostate cancer, recurrence after surgery, and response to subsequent therapy. However, the clinical implications often are difficult to interpret. Ulmert and colleagues report use of a positron-emitting labeled monoclonal antibody directed to a unique PSA epitope to noninvasively image PSA-positive prostate cancer xenografts and to measure both androgen-stimulated PSA expression and androgen therapy-responsive PSA decreases.

References

Jan 17, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Annick D Van den Abbeele, Ramsey D Badawi
Feb 7, 2008·Nature Clinical Practice. Oncology·Wolfgang A WeberJohannes Czernin
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Apr 22, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Wolfgang A Weber
Mar 31, 2010·Seminars in Nuclear Medicine·Tove Olafsen, Anna M Wu
Jun 30, 2010·Current Topics in Medicinal Chemistry·Ronnie C Mease
Sep 8, 2010·The New England Journal of Medicine·Keith T FlahertyPaul B Chapman
Jun 30, 2011·Medicinal Chemistry·Gregory W SeverinR Jerry Nickles
Dec 14, 2011·Cancer Biotherapy & Radiopharmaceuticals·Mario De Decker, J Harvey Turner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
R A GhosseinJ Rosai
The Journal of the Louisiana State Medical Society : Official Organ of the Louisiana State Medical Society
H Yu, H Berkel
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
Alessandro RuggieroJan Grimm
© 2021 Meta ULC. All rights reserved